NK

Nitaben Kamlesh Bhai Patel

Active Director Director DIN 03404517
DIN 03404517 First appointment Apr 2011 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2011
Shareholding value •••• Premium profile

About Nitaben Kamlesh Bhai Patel

Data last updated:

Nitaben Kamlesh Bhai Patel is a Director at Wynburg Pharmaceuticals Private Limited (since 2011). The company operates in Pharma. Wynburg Pharmaceuticals Private Limited reported revenue of ₹1.10 Cr (FY 2025).

DIN 03404517
Primary Designation Director
Industry Pharma
First Appointment 26 Apr 2011
Oldest Company Age 15 yrs
Largest company Wynburg Pharmaceuticals Private Limited · ₹1.10 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Apr 20112011₹1.10 Cr (FY 2025)Active

Board colleagues of Nitaben Kamlesh Bhai Patel

Directorship timeline

Open interactive timeline →
Wynburg Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Nitaben Kamlesh Bhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nitaben Kamlesh Bhai Patel

Nitaben Kamlesh Bhai Patel currently holds 1 directorship: Wynburg Pharmaceuticals Private Limited (Director, since 26 Apr 2011, revenue ₹1.10 Cr (FY 2025)).

Nitaben Kamlesh Bhai Patel was first appointed on 26 Apr 2011 as Director at Wynburg Pharmaceuticals Private Limited.

The current boards of Nitaben Kamlesh Bhai Patel's companies include Kamlesh Vasudev Bhai Patel (Wynburg Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available